Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock subscribed but not issued
Additional paid-in capital
Accumulated deficit
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2021   334,030,348 0      
Beginning balance at Dec. 31, 2021 $ 36,299 $ 334 $ 0 $ 134,920 $ (97,392) $ (1,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   10,000        
Exercise of stock options $ 3     3    
Cashless exercise of stock options (in shares) 200,000          
Cashless exercise of warrants (in shares) 234,961          
Release of shares under stock grants (in shares)   356,938        
Shares issued as purchase consideration - business acquisition (in shares)   2,343,750        
Shares issued as purchase consideration - business acquisition $ 1,500 $ 3   1,497    
Purchase of minority interests in certain of the Company’s subsidiaries (2,000)     (2,165)   165
Common stock issued to settle obligations (in shares)   375,000        
Common stock issued to settle obligations 274 $ 1   273    
Conversion of promissory notes to equity (in shares)   1,142,858        
Conversion of promissory notes to equity 400 $ 1   399    
Distributions to non-controlling interests (184)         (184)
Stock-based compensation 5,024     5,024    
Net income 6,137       6,011 126
Ending balance (in shares) at Jun. 30, 2022   338,693,855 0      
Ending balance at Jun. 30, 2022 47,453 $ 339 $ 0 139,951 (91,381) (1,456)
Beginning balance (in shares) at Dec. 31, 2021   334,030,348 0      
Beginning balance at Dec. 31, 2021 36,299 $ 334 $ 0 134,920 (97,392) (1,563)
Ending balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Ending balance at Dec. 31, 2022 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Beginning balance (in shares) at Mar. 31, 2022   335,558,206 2,717      
Beginning balance at Mar. 31, 2022 43,587 $ 336 $ 2 138,064 (93,204) (1,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares)     (2,717)      
Issuance of subscribed shares $ 0   $ (2) 2    
Cashless exercise of stock options (in shares) 200,000          
Cashless exercise of warrants (in shares) 234,961          
Release of shares under stock grants (in shares)   356,938        
Shares issued as purchase consideration - business acquisition (in shares)   2,343,750        
Shares issued as purchase consideration - business acquisition $ 1,500 $ 3   1,497    
Purchase of minority interests in certain of the Company’s subsidiaries (2,000)     (2,165)   165
Distributions to non-controlling interests (83)         (83)
Stock-based compensation 2,553     2,553    
Net income 1,896       1,823 73
Ending balance (in shares) at Jun. 30, 2022   338,693,855 0      
Ending balance at Jun. 30, 2022 47,453 $ 339 $ 0 139,951 (91,381) (1,456)
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Ending balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Ending balance at Mar. 31, 2023 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 $ 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares) 5,025 75,025 (70,000)      
Issuance of subscribed shares $ 2   $ (39) 41    
Exercise of stock options (in shares) 157,752 157,752        
Exercise of stock options $ 35     35    
Release of shares under stock grants (in shares)   349,999        
Release of shares under stock grants 0 $ 1   (1)    
Warrants issued in connection with debt 5,454     5,454    
Shares issued as purchase consideration - business acquisition (in shares)   6,580,390        
Shares issued as purchase consideration - business acquisition 2,994 $ 7   2,987    
Conversion of preferred stock to common stock (in shares)   21,383,040        
Conversion of preferred stock to common stock 15,823 $ 21   15,802    
Purchase of minority interests in certain of the Company's subsidiaries (in shares)   450,000        
Purchase of minority interests in certain of the Company’s subsidiaries 0 $ 1   4   (5)
Common stock issued to settle obligations (in shares)   400,000        
Common stock issued to settle obligations 160     160    
Distributions to non-controlling interests (81)         (81)
Stock-based compensation 505     505    
Net income (1,599)       (1,603) 4
Ending balance (in shares) at Jun. 30, 2023   371,614,758 0      
Ending balance at Jun. 30, 2023 80,904 $ 372 $ 0 167,652 (85,527) (1,593)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued to purchase property and equipment (in shares)   740,741        
Common stock issued to purchase property and equipment 300 $ 1   299    
Stock Issued During Period, Shares, Issued Under Licensing Agreement   3,083        
Stock Issued During Period, Value, Issued Under Licensing Agreement 1     1    
Beginning balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Beginning balance at Mar. 31, 2023 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares)   5,025 (5,025)      
Issuance of subscribed shares 0   $ (2) 2    
Exercise of stock options (in shares)   157,752        
Exercise of stock options 35     35    
Release of shares under stock grants (in shares)   349,999        
Release of shares under stock grants 0 $ 1   (1)    
Conversion of preferred stock to common stock (in shares)   21,383,040        
Conversion of preferred stock to common stock 15,823 $ 21   15,802    
Purchase of minority interests in certain of the Company's subsidiaries (in shares)   450,000        
Purchase of minority interests in certain of the Company’s subsidiaries 0 $ 1   4   (5)
Common stock issued to settle obligations (in shares)   400,000        
Common stock issued to settle obligations 160     160    
Distributions to non-controlling interests (47)         (47)
Stock-based compensation 299     299    
Net income (935)       (958) 23
Ending balance (in shares) at Jun. 30, 2023   371,614,758 0      
Ending balance at Jun. 30, 2023 80,904 $ 372 $ 0 167,652 $ (85,527) $ (1,593)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued to purchase property and equipment (in shares)   740,741        
Common stock issued to purchase property and equipment 300 $ 1   299    
Stock Issued During Period, Shares, Issued Under Licensing Agreement   1,290        
Stock Issued During Period, Value, Issued Under Licensing Agreement $ 0     $ 0